Pfizer CEO tests positive for COVID-19, experiencing 'very mild symptoms'

Pfizer's CEO tested positive for COVID-19 and is experiencing "very mild symptoms," he announced Monday.

"I would like to inform the public that I have tested positive for COVID-19," the biopharmaceutical company's chairman and CEO, Albert Bourla, said in a statement.

Bourla said he was isolating in place and following all public health precautions.

"I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms," Bourla also posted on Twitter. "(I) have started a course of Paxlovid."

'Permanent shock' to nursing homes? Facilities fail to replace workers who quit after COVID outbreaks

'We need to hurry!' Georgia high school football players rescue trapped woman from car crash

Paxlovid is not approved, according to Pfizer, but is authorized for emergency use by the FDA to treat mild-to-moderate COVID-19 in high-risk patients age 12 and older, weighing at least 88 pounds, with positive results of SARS-CoV-2 viral testing.

For more information on Paxlovid, visit

Previously: COVID antivirals can save lives, but access is still limited. Biden announces plan to change that.

Natalie Neysa Alund covers trending news for USA TODAY. Reach her at and follow her on Twitter @nataliealund.

This article originally appeared on USA TODAY: Pfizer CEO Albert Bourla tests positive for COVID-19, takes Paxlovid